Posted by zeugma on March 14, 2003, at 20:42:50
In reply to Re: Zyprexa TD: Real Concern?, posted by xjs7 on March 13, 2003, at 2:09:07
Here's a study that claims to identify the relative risk of EPS with particular AP's including atypicals http://www.hplc1.com/lien/neurol.html
This study may not be the most recent, but it seems interesting. According to the authors, Abilify may be the only AP besides clozapine that does not carry a risk of TD.
poster:zeugma
thread:208427
URL: http://www.dr-bob.org/babble/20030314/msgs/209194.html